Invention Grant
- Patent Title: 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
-
Application No.: US15226240Application Date: 2016-08-02
-
Publication No.: US09833445B2Publication Date: 2017-12-05
- Inventor: Sheila DeWitt
- Applicant: DeuteRx, LLC
- Applicant Address: US MA Andover
- Assignee: DEUTERX, LLC
- Current Assignee: DEUTERX, LLC
- Current Assignee Address: US MA Andover
- Agency: Goodwin Procter LLP
- Main IPC: C07D213/72
- IPC: C07D213/72 ; A61K31/4439 ; C07D417/12 ; C07D277/34 ; C07B59/00
Abstract:
The invention provides 5-deuterium-enriched 2,4-thiazolidinediones (e.g., 5-[4-[2-(5-ethyl-2-pyridyl)-2-oxoethoxy]benzyl]-5-deutero-thiazolidine-2,4-dione), deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treatment using the same.
Public/Granted literature
- US20170049762A1 5-DEUTERO-2,4-THIAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME Public/Granted day:2017-02-23
Information query
